Advertisement
 

Colgate Buys World Rights to Xytronyx Kit

INDUSTRY NOTES

November 07, 1987

Xytronyx Inc. said Colgate-Palmolive Co. has exercised its option for exclusive worldwide distribution rights to a detection kit for periodontal disease that Xytronyx is developing. Xytronyx will receive $500,000 from Colgate-Palmolive when documentation is complete.

Colgate-Palmolive paid Xytronyx $300,000 last February for an option to the rights and will pay the company $600,000 more if the product receives market approval from the Food and Drug Administration.

Xytronyx retained the right to manufacture or subcontract the manufacture of the product.

Advertisement
Los Angeles Times Articles
|
|
|